Wu S, Qiu Z, Shi H, Yu W, et al. High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy. BMC Cancer 2025;25:926.
PMID: 40410780